No need to change supplier when moving
from RUO to GMP.
We ensure continuity, consistency, and scalability across all phases.
PAN-Biotech supports customers throughout the entire life cycle of biopharmaceutical,
cell therapy, gene therapy, and advanced therapy development. Our portfolio is designed
to meet the evolving requirements of research, preclinical development, clinical
manufacturing, and commercial production, ensuring a seamless transition from early
discovery to market-ready products.
During the research and development phase, scientists rely on high-quality catalog products
for process development, assay optimization, proof-of-concept studies, and exploratory
research. These research-use materials provide the flexibility and performance required to
accelerate innovation and generate reliable data.
As projects advance into preclinical development, product requirements become more
specific and process scalability becomes increasingly important. PAN-Biotech provides
customized solutions tailored to individual process needs, helping customers establish robust
workflows while preparing for future regulatory and manufacturing requirements. This stage
enables the development of scalable processes and supports a smooth transition toward
clinical applications.
For clinical development and commercial manufacturing, PAN-Biotech offers GMP-ready and
GMP-compliant solutions designed to meet the highest standards of quality, consistency,
traceability, and regulatory compliance. Our clinical-grade products support Phase I, Phase
II, and Phase III clinical trials as well as commercial production, helping customers navigate
complex development pathways while maintaining product quality and supply security.
By combining research products, customized solutions, and GMP-compliant
manufacturing capabilities, PAN-Biotech serves as a long-term partner across the entire
development journey. This integrated approach reduces development risk, simplifies
technology transfer, and enables a more efficient path from scientific discovery to clinical
and commercial success.
